Big Data Analytics in the Pharmaceutical Industry: Drug Discovery and Development
American Journal Of Big Data · 30.04.2025 · 6 (2) · 1-5
DOI: 10.71465/ajbd851 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal Of Big Data, online erschienen am 30.04.2025. Verfasst von Dr. Oliver Thompson. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The pharmaceutical industry is increasingly turning to Big Data analytics to accelerate drug discovery and development processes. By analyzing vast datasets from diverse sources such as clinical trials, genomics, and patient records, pharmaceutical companies can gain insights into drug efficacy, safety, and potential market success. This paper explores the applications of Big Data in drug development, highlighting how it is transforming the way drugs are identified, tested, and developed.
Zitieren
APA
Thompson, D. O. (2025). Big Data Analytics in the Pharmaceutical Industry: Drug Discovery and Development. American Journal Of Big Data, 6(2), 1-5. https://doi.org/10.71465/ajbd851
Vancouver
Thompson DO. Big Data Analytics in the Pharmaceutical Industry: Drug Discovery and Development. American Journal Of Big Data. 2025;6(2):1-5. doi:10.71465/ajbd851
BibTeX
@article{Thompson2025,
author = {Thompson, Dr. Oliver},
title = {Big Data Analytics in the Pharmaceutical Industry: Drug Discovery and Development},
journal = {American Journal Of Big Data},
year = {2025},
volume = {6},
number = {2},
pages = {1--5},
doi = {10.71465/ajbd851}
}
EUVIMED